Myc proteins as therapeutic targets.

Oncogene
W C Gustafson, W A Weiss

Abstract

Myc proteins (c-myc, Mycn and Mycl) target proliferative and apoptotic pathways vital for progression in cancer. Amplification of the MYCN gene has emerged as one of the clearest indicators of aggressive and chemotherapy-refractory disease in children with neuroblastoma, the most common extracranial solid tumor of childhood. Phosphorylation and ubiquitin-mediated modulation of Myc protein influence stability and represent potential targets for therapeutic intervention. Phosphorylation of Myc proteins is controlled in-part by the receptor tyrosine kinase/phosphatidylinositol 3-kinase/Akt/mTOR signaling, with additional contributions from Aurora A kinase. Myc proteins regulate apoptosis in part through interactions with the p53/Mdm2/Arf signaling pathway. Mutation in p53 is commonly observed in patients with relapsed neuroblastoma, contributing to both biology and therapeutic resistance. This review examines Myc function and regulation in neuroblastoma, and discusses emerging therapies that target Mycn.

References

Oct 1, 1992·Nature·L KretznerR N Eisenman
Oct 1, 1992·Journal of Child Neurology·B S RussmanL Barker
Apr 3, 1992·Cell·G I EvanD C Hancock
Aug 1, 1990·Molecular and Cellular Biology·G W KrystalJ F Battey
Jan 1, 1992·Genes & Development·E M BlackwoodR N Eisenman
Jan 1, 1992·Genes & Development·G J KatoC V Dang
Nov 23, 1990·Science·T K BlackwellH Weintraub
Oct 31, 1985·The New England Journal of Medicine·R C SeegerD Hammond
Sep 1, 1993·Molecular and Cellular Biology·T K BlackwellH Weintraub
Mar 8, 1996·The Journal of Biological Chemistry·B Smith-SørensenR Bernards
Aug 1, 1997·Genes & Development·C J ThutR Tjian
Mar 28, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N KeshelavaC P Reynolds
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KamijoC J Sherr
Mar 17, 1999·Molecular Cell·R SearsJ R Nevins
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·R T PetersonS L Schreiber
Jun 24, 1999·The New England Journal of Medicine·N BownN Van Roy
Sep 15, 1999·Genes & Development·R MaestroG J Hannon
Nov 13, 1999·Nature Cell Biology·J D WeberD Bar-Sagi
Dec 28, 1999·Molecular and Cellular Biology·S B McMahonM D Cole
Oct 14, 2000·Annual Review of Cell and Developmental Biology·C GrandoriR N Eisenman
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L CohnM Haber
Dec 7, 2000·Medical and Pediatric Oncology·N KeshelavaC P Reynolds

❮ Previous
Next ❯

Citations

Feb 22, 2011·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jia YongshengZheng Jianquan
Nov 24, 2012·Cell Death and Differentiation·P Y LiuT Liu
Jun 9, 2010·Nature Medicine·Masayuki Fukata, Maria T Abreu
Sep 26, 2013·Nature Reviews. Cancer·Bengt Hallberg, Ruth H Palmer
Mar 29, 2011·Oncogene·A R WasylishenL Z Penn
Apr 14, 2012·Advances in Anatomic Pathology·Elizabeth G DemiccoAlexander J Lazar
Mar 17, 2012·Pigment Cell & Melanoma Research·Irina PshenichnayaFriedrich Beermann
Dec 25, 2010·Doklady. Biochemistry and Biophysics·I B CheglakovA A Shtil
May 26, 2011·Case Reports in Oncology·Cornelia ThenFuat Oduncu
Jul 23, 2011·Genes & Cancer·Anna FrenzelMarie Arsenian Henriksson
Apr 5, 2013·PLoS Genetics·Bethan E PhillipsPhilip J Atherton
Mar 8, 2013·PloS One·Jingbo QiaoDai H Chung
Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Changxian Shen, Peter J Houghton
Jan 21, 2014·Pediatric Research·Keren ShichrurSmadar Avigad
Jun 8, 2014·Journal of the National Cancer Institute·Pei Y LiuTao Liu
Feb 25, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yohko YamaguchiTakehiko Kamijo
Aug 22, 2014·Cell Death & Disease·L DorstynS Kumar
Jul 12, 2014·Journal of Cancer Research and Clinical Oncology·Rita de Cássia S AlvesAdriana Vial Roehe
Nov 27, 2010·Journal of Cancer Research and Clinical Oncology·Chun Sun, Yin Kun Liu
Oct 1, 2011·Expert Review of Neurotherapeutics·William Clay Gustafson, Katherine K Matthay
Jan 21, 2014·Journal of Pediatric Surgery·Carmelle RomainDai H Chung
Jun 15, 2012·European Urology·Atish D ChoudhuryTapio Visakorpi
Jan 17, 2012·Journal of Proteomics·Bhagyashree ManivannanAnne Camille La Flamme
Nov 18, 2015·Current Opinion in Pediatrics·Rochelle Bagatell, Susan L Cohn
Aug 19, 2011·Seminars in Cancer Biology·Ulrica K WestermarkMarie Arsenian Henriksson
Oct 1, 2015·The Journal of Pathology·Ailbhe Jane Brazel, Douglas Vernimmen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.